Agendia has named Richard Bender as VP and chief medical officer.
Bender was medical director in the oncology division of Quest Diagnostics, and he was involved in clinical oncology at Kaiser Permanente. Bender also was on the executive board of San Diego’s Hospice and the American Cancer Society and he was an instructor at the UCLA School of Medicine.
PsychoGenics has named Mark Day to be senior director of cognitive neuroscience. Day formerly was involved in developing cognitive treatments for schizophrenia and Alzheimer’s disease at Wyeth Neuroscience and at GlaxoSmithKline.
Pacific Biomarkers has named Tara Hennen, a member of the company’s science and technology group, to be manager of its Biomarker Lab Services business.